Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

A man had bad reactions to a hair loss treatment called DNCB.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Cancer treatments often cause skin, nail, and hair problems.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.